Beijing Tongrentang (SHA:600085), through branch Tongrentang Pharmaceutical Factory, obtained a class III product license from Health Canada for the Shiyi Qingwen Pills, according to a Shanghai bourse filing on Thursday.
The traditional Chinese medicine is used to eliminate heat toxins and treat viral influenza, headache, body aches and chills.
The drugmaker's shares fell 2% during the afternoon trade.